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Inflammation is part of the body’s responses to infections and injuries, but 
an improper inflammatory response together with the production of proin-
flammatory molecules can cause serious diseases. Multiple sclerosis (MS) is 
an autoimmune inflammatory disease that affects the central nervous sys-
tem. The disease is the primary cause of disability among young adults aged 
between 20-40 years. The reason of MS is unknown and no treatment can 
fully cure the outcomes of it. There are disease-modifying drugs used to 
slow down the progression of MS. Such drugs are not always effective, are 
of high cost and have side effects. Therefore, it can be discussed whether a 
complementary alternative in the form of a natural source may be more 
efficient in treating MS than the used drugs. An example of one such natural 
source is fish due to the anti-inflammatory properties of omega-3 polyun-
saturated fatty acids that exist in fish and fish oil. The aim of this thesis was 
to make a review by extracting information from available literature as well 
as published scientific articles about the link between the dietary intake of 
omega-3 polyunsaturated fatty acids (particularly from fish) and an en-
hanced immune system. Another purpose was to shed light on the role such 
fatty acids play in decreasing inflammation and lowering the risk of MS and 
treating the outcomes of it.  
There are not so many clinical trials involving the research about if ome-
ga-3 fatty acid intake helps to reduce the risk and treat the outcomes of MS. 
Most of the available studies state that omega-3 fatty acid intake improve 
the overall quality of life and boost the immune system. Studies have prov-
en that omega-3 fatty acids reduce the expression and production of proin-
flammatory molecules. Several studies have also shown that the high intake 
of omega-3 fatty acids help to treat the outcomes of MS such as the physical 
disability, fatigue, and depression. Further information about the role of 
nutrigenomics in the immune system functionality is needed in order to 
know if there is a direct link between MS and the intake of omega-3 fatty 
acids.  
Keywords: Omega-3 PUFA, autoimmune disease, immune system, inflamma-
tion, metabolism and multiple sclerosis.  
Abstract 
En inflammation är en del av det medfödda immunsystemets svar på skador 
och infektioner. Ett felaktigt inflammatoriskt svar kan dock orsaka en rad 
olika kroniska sjukdomar.  
Multipel skleros (MS) är en autoimmun inflammatorisk kronisk sjukdom 
i centrala nervsystemet. MS är den främsta orsaken till funktionshinder 
bland unga vuxna. Orsaken till sjukdomen är okänd, och det finns ingen 
terapi som fullständigt kan behandla MS. Vissa sjukdomsmodifierande 
läkemedel används för att förhindra och fördröja sjukdomens progression, 
men dessa är kostsamma och ger biverkningar. Det kan därför diskuteras om 
ett komplementärt alternativ från en naturlig källa kan vara effektivare i 
behandlingen av MS än de använda läkemedlen. Ett exempel på en sån 
naturlig källa är fisk, vars fleromättade omega-3 fettsyror har 
antiinflammatoriska egenskaper. Syftet med denna avhandling var att 
sammanställa information från tillgänglig litteratur samt publicerade 
vetenskapliga artiklar om sambandet mellan intaget av fleromättade omega-
3 fettsyror genom kosten (särskilt från fisk) och ett förstärkt immunförsvar. 
Syftet var också att granska vilken roll sådana fettsyror har i minskandet av 
inflammation och förbättrandet i behandlingen av MS. 
 Det finns endast ett fåtal kliniska prövningar som involverar forskning 
kring hur omega-3 intaget kan påverka MS. De flesta tillgängliga studier 
visar emellertid att omega-3 fettsyror förbättrar den totala livskvaliteten och 
ökar immunförsvarets effektivitet. Studier visar också att omega-3 
fettsyrorna hämmar bildningen av proinflammatoriska molekyler vilket 
följaktligen minskar inflammationen. Det är också bevisat i vissa studier att 
ett högt intag av omega-3 fettsyror kan hjälpa vid behandling av symptom 
på MS såsom fysiska funktionshinder, trötthet och depression. Ytterligare 
information om nutrigenomikens roll för immunsystemets funktionalitet är 
nödvändig för att fastställa om det finns en direkt länk mellan intaget av 
omega-3 och förbättring av livskvaliteten för personer som är sjuka i MS.  
Nyckelord: Omega-3 fettsyror, autoimmuna sjukdomar, immunsystemet, 
inflammation, metabolism och multipel skleros.  
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MS is an autoimmune inflammatory chronic disease that affects the central nerv-
ous system by causing serious damage to the myelin sheath, which encloses the 
nerve cells (Riccio & Rossano, 2015). The disease interferes with the ability of the 
different parts of the nervous system to communicate in order to function (Stauf-
fer, 2006). It results in neuronal degradation and major life-long damage, both 
mentally and physically. The cause of the disease is unknown, but several factors 
that might influence and trigger it are suggested (Altowaijri et al., 2017). Such 
factors include genetics, environmental factors, vascular disease risk factors, and 
lifestyle together with dietary habits. MS is one of the primary causes of disability 
within young-aged people (20-40 years) (da Cunha Matta & Orsini, 2017). Ap-
proximately 2.5 million people worldwide suffer from the disease and women are 
more affected than men with a ratio of 2-3:1. There is no known cure for MS, but 
some disease-modifying drugs help to reduce the severity of the outcome of cer-
tain symptoms (Riccio & Rossano, 2015). Each patient reacts to such drugs differ-
ently, depending on every patient’s individual case. Therefore, it can be discussed 
whether a treatment from a natural source can be more efficient in the treatment of 
MS than the used drugs. One such natural source is fish, due to the anti-
inflammatory properties of omega-3 polyunsaturated fatty acids that exist in fish 
and fish oil. It is proposed that such fatty acids can be efficient to improve or limit 
the outcomes of MS (Riccio & Rossano, 2015).  
The aim of this thesis was, therefore, to make a literature review about the role 
of dietary intake specifically omega-3 polyunsaturated fatty acid intake originated 
from fish, in the improvement of the immune system's functionality. Another pur-
pose was to shed light on the effects of omega-3 fatty acid intake in lowering the 
episode of inflammation, together with a focus on the effects of such fatty acids in 
lowering the risk of MS and treating the outcomes of it. Examples of this are 
downregulating the inflammation caused by MS at the molecular level, and slow-
ing down progression rate and physical disability.   
 
1 Introduction 
10 
 
This thesis was literature-based, and to find suitable literature relevant published 
scientific papers and articles were searched on Web of Science, Scopus, and Pub-
Med and categorized to review the required information. Examples of the key-
words used were: “Omega-3 fatty acids” in a combination with “metabolism”, 
“autoimmune disease”, “autoimmunity”, “inflammation”, “multiple sclerosis” and 
“immune system. Further information was obtained from online books available at 
SLU’s library search device Primo.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 Methods 
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3.1 Fatty acids  
Fatty acids (FA) are the primary components in lipid classes, they serve as struc-
tural components in cells and as energy substrates that store energy in adipose 
tissues (Tvrzicka et al., 2011). Additionally, they play a role as ligands of nuclear 
receptors influencing gene expression (Kremmyda et al., 2011).  
FA are carboxylic acids (-COOH) that consist of a hydrocarbon chain bound to 
an alkyl unbranched end methyl tail -CH3 (Mir et al., 2016). The chain can be of 
variant lengths, in mammals it usually ranges from 12 to 24 carbon atoms and it 
can be saturated or unsaturated (Tvrzicka et al., 2011). Saturated fatty acids (SFA) 
have straight chains without double bonds between the carbon atoms in the hydro-
carbon chain (Mir et al., 2016). SFA can be long, medium or short-chained (Tvr-
zicka et al., 2011). Contrariwise, unsaturated fatty acids have one (monounsaturat-
ed fatty acids -MUFA-) or more double bonds (polyunsaturated fatty acids -
PUFA-) between the carbon-carbon atoms in the hydrocarbon chain (Mir et al., 
2016). The position of the first double bond (from the -CH3 tail) determines the 
structure and properties of the PUFA, when the double bond is at the third carbon 
the PUFA is called omega-3 (n-3 or ω-3), and when the first double bond is at the 
sixth carbon atom the PUFA is called omega-6 (n-6 or ω-6). The position of the 
last double bond is of great significance, it determines which biological functions 
the PUFA will possess. For instance, some PUFA possesses important regulating 
functions of the nervous system and the brain. The generated lipid mediators from 
long-chained (LC) PUFA have substantial functions in regulating immunity. 
 
3 Background 
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3.2 Biosynthesis of long chain polyunsaturated fatty acids 
Mammals including humans are unable to produce certain FA, such as n-3 PUFA 
(Mir et al., 2016) since humans lack the enzymes desaturases that are necessary to 
replace hydrogen atoms from the hydrocarbon chain of a FA with a double bond. 
Desaturases establish the carbon-carbon double bond (C = C) and produce Linole-
ic acid (LA; 18:2n-6) and α-Linolenic acid (ALA; 18:3n-3). Thus, both LA and 
ALA are considered essential FA (EFA) and should be supplied from the diet 
(Tvrzicka et al., 2011). Additional elongation and desaturation processes of LA 
and ALA are needed to establish LC PUFA. The human body converts LA to γ-
linolenic acid (18:3 n-6) and dihomo- γ- linolenic acid (20:3 n-6) for further syn-
thesis of arachidonic acid (AA ; 20:4 n-6) (Schmitz & Ecker, 2008). The latter can 
be converted to docosapentaenoic acid (22:5 n-6) or eicosanoids. Moreover, ALA 
is also converted to stearidonic acid (18:4 n-3) and eicosatetraenoic acid (20:4 n-3) 
to synthesize eicosapentaenoic acid (EPA; 20:5 n-3) which in turn is metabolized 
to docosahexaenoic acid (DHA; 22:6 n-3). These processes are driven by a series 
of desaturase- and elongase-enzymes, which are the same for both n-3 and n-6. 
Due to that, there is a competition between those PUFA in the conversion process. 
Eicosanoids differ according to the PUFA they are converted from, the mediators 
derived from EPA and DHA possess anti-inflammatory properties, whereas the 
ones derived from AA have proinflammatory properties (Schmitz & Ecker, 2008). 
The aforementioned processes of producing LC PUFA are possible in humans but 
not always sufficient, therefore such FA are considered as conditionally essential 
(Tvrzicka et al., 2011). The gene encoding the human desaturase enzymes varies 
depending on each person’s genetics and affects the metabolism of FA and plasma 
lipid profiles (Kremmyda et al., 2011). 
The human body is unable to synthesize ALA, so it needs to be provided from 
the diet, whereas the body is able to synthesize EPA and DHA from ALA, only 
not in sufficient amounts (Tvrzicka et al., 2011). ALA is found in flaxseed oil and 
walnuts. Both EPA and DHA are abundant in the flesh of oily fish such as sar-
dines, trout, salmon, fresh tuna, and herring, and even in non-oily fish but in lower 
concentrations. The fish are able to synthesize such FA like mammals and hu-
mans, but not in sufficient amounts. Instead, the fish acquires most of such FA by 
marine bacteria that synthesize them (Mir et al., 2016). Such bacterial species are 
for example Shewanella spp.and Photobacterium (Wall et al., 2010). The content 
of n-3 PUFA in fish varies depending on several factors, such as the total fat con-
tent of the fish and the geographical location of the waters where the fish exist. 
Table 1. 
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Table1. n-3 content in different fish species, developed by using Table 1 from the review by (Wall et 
al., 2010).  
Fish species n-3 (EPA&DHA) content per 100 g fish 
Atlantic herring 2.01 
Atlantic salmon 1.28-2.15 
Sardines 1.15-2 
Rainbow trout 1.15 
Tuna 
Tuna (canned) 
0.28-1.51 
                                   0.31 
Cod 
Scallop 
0.28 
0.2 
 
3.3 Cellular effects of different fatty acids 
n-3 PUFA affect the neuronal cell membrane health since both EPA and DHA are 
present in the neural membrane of phospholipids and are important for membrane 
fluidity (Rivera Jr & Watson, 2014). The profile of phospholipids influences the 
structure of the cell membrane and consequently the activity of the membrane-
associated proteins (enzymes, receptors, and transporters) (Kremmyda et al., 
2011). Another factor that has an impact on membrane fluidity is the degree of FA 
unsaturation. Membrane-FA are usually cis-PUFA, and their double bonds con-
duct a folding of ~ 60o of the hydrocarbon chain. Due to that, cis-PUFA chains 
occupy greater space and increase membrane fluidity. On the contrary, SFAs and 
trans-unsaturated FAs occupy less space, thus decreasing membrane fluidity. 
Therefore, increasing the number of phospholipids would not increase the mem-
brane fluidity. The increase in the degree of unsaturation of the phospholipids is 
what has an effect on membrane fluidity (Kremmyda et al., 2011).  
PUFA are important in transporting fat-soluble vitamins such as vitamins A, D, 
E and K. Additionally, n-3 PUFA play an essential role in blood clotting (Wall et 
al., 2010) and regulation of blood pressure, eicosanoids production, metabolism of 
minerals and affect the lipoprotein concentrations (Tvrzicka et al., 2011). The 
latter covers the cell membrane and comprises a number of phospholipids (Krem-
myda et al., 2011). DHA is present in high concentrations in the eye retina and 
nervous tissues serving a fundamental function in the signal transduction between 
neurons (Tvrzicka et al., 2011). The n-3 PUFA family share common anti-
inflammatory properties (Rivera Jr & Watson, 2014), they also serve as anti-
inflammatory agents and possess immunomodulatory properties by inhibiting the 
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T lymphocyte activation (Tvrzicka et al., 2011) and inhibit the expression of pro-
inflammatory molecules e.g. eicosanoids derived from AA (Calder, 2006). EPA 
influences the production of proinflammatory cytokines such as tumor necrosis 
factor TNF-α causing their production to decrease (Kremmyda et al., 2011). Thus, 
n-3 PUFA are suggested to be used as a therapeutic alternative or complementary 
medicine for some diseases (Tvrzicka et al., 2011). 
 
3.4 Immunity and autoimmune diseases  
The immune system is comprised of the mechanisms that protect the human body 
from foreign and pathogenic microorganisms such as bacteria, fungi, and virus 
(Devereux, 2002). It consists of organs, cells, and molecules that are distributed in 
the whole body (Esser, 2016). The immune system is divided into two systems: the 
innate immune system (natural/non-specific) and the adaptive immune system 
(acquired through lifespan/specific). The latter comprises B lymphocytes (B-cells) 
and T lymphocytes (T-cells) as the main cells in this system (Esser, 2016). Such 
cells originate in the bone marrow and possess immunoglobulin proteins (antibod-
ies) on their surface (Stauffer, 2006). Those antibodies recognize strange and 
harmful substances (antigens) and consequently produce a secretion of soluble 
antibodies that bind and immobilize the antigens and target them for further decay.  
An inflammation is part of the innate immune system’s responses and is the 
body’s direct reaction to infections caused by harmful pathogens e.g., viruses, 
bacteria, and injuries e.g. damaged cells (Calder, 2006). The response is character-
ized by redness and swollenness caused by the increased blood flow and cellular 
permeability to the infection site in order to repair infected/damaged cells (Stauf-
fer, 2006). Inflammation is initiated when leukocytes are drawn to an infection site 
due to the enhanced blood supply and vascular permeability. Phagocytes contrib-
ute by migrating to the infection site and secrete cytokines, which in turn regulate 
the leukocyte number and send more of them to the infection location. Cytokines 
are small proteins that affect the activity of other cells. An example of cytokines is 
t TNF-α. The inflammation is terminated when the site is eradicated properly and 
programmed cell death of the immune cells is achieved. However, some of the 
immune cells remain in a rest condition and monitor for another infection. Never-
theless, an improper inflammatory response together with the production of cyto-
kines and inflammatory molecules such as eicosanoids derived from arachidonic 
acid can cause serious chronic diseases (Calder, 2006). Accordingly, inflammation 
is considered to play a role in the pathogenicity and occurrence of certain diseases.   
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Besides the defense against harmful microorganisms, the immune system has 
another essential task of immunosuppression (Stauffer, 2006), which retains the 
balance inside the body and prevents immune cells from attacking and damaging 
the body’s own cells and tissues. The immune system thus possesses a fundamen-
tal role in survival by distinguishing between the body’s own cells and the foreign 
cells and substances. A dysfunction or disorder in the immune system can cause 
autoimmune diseases to arise (Devereux, 2002). In the case of autoimmunity, the 
immune system senses the body’s own cells as foreign and attacks them (Stauffer, 
2006). The recognition of the body’s own cells is programmed into developing 
populations of B and T cells, such self-reactive cells are activated in the presence 
of self-antigen.  
Autoimmune diseases can occur depending on several genetic and environmen-
tal factors including the exposure to environmental toxins and some dietary com-
ponents (Ceribelli, Generali & Selmi 2016).  
 
3.5 The central nervous system (CNS) 
CNS consists of the brain and spinal cord and comprises two types of cells: neu-
rons and glial cells (Stauffer, 2006). Glial cells provide support and are classified 
into three subtypes of cells: astrocytes, oligodendrocytes, and microglia. A neu-
ron’s main function is to transmit electrical and chemical signals to other neurons 
via synapses to, from and within the CNS. An insulating substance known as mye-
lin surrounds neurons. Myelin is produced by oligodendrocytes and comprises 
lipids and proteins that enable it to attach to the surface of neurons (Stauffer, 
2006). There are gaps in the myelin sheath covering an axon, leaving space for 
protein channels for ion transport in and out the axon. Neurons can be stimulated 
due to various factors, including temperature or mechanical force (Brodal, 2010). 
When they are stimulated, an electrical cascade is created, also called an action 
potential. Besides the insulating function, myelin also provides an enhanced speed 
of the axon potentials. 
The CNS is isolated from the rest of the body by a barrier that is composed of 
endothelial cells surrounding astrocytes. The barrier is called Blood Brain Barrier 
(BBB) and has a function to protect the CNS from foreign substances. When an 
inflammation manifests within the CNS, astrocytes are capable of producing the 
cytokine TNF-α. Which in turn regulates the migration of leukocytes into the BBB 
(Stauffer, 2006). In addition to that, astrocytes are able to produce other cytokines 
that induce and stimulate the migration of T cells to the location of the inflamma-
tion. 
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3.6 Multiple sclerosis (MS) 
MS is an autoimmune inflammatory chronic disease that affects the CNS by de-
stroying the myelin sheath (demyelination) (Stauffer, 2006). This leads to the for-
mation of plaques in the myelin-missing areas. An activated T-cell migrates across 
BBB due to disruptions in the barrier and recognizes the myelin sheath as a for-
eign substance. It is not completely clear why this happens, perhaps the T-cell 
recognizes the component proteins of myelin as an analogous antigen and thus 
attacks it. T cells promote the production of anti-myelin antibodies by B cells. 
This, in turn, promotes an inflammatory response, which in turn is responsible for 
the migration of phagocytes to the site of inflammation and degradation of oli-
godendrocytes. The sites of inflammation are visible as lesions, causing a reduced 
or inhibited distribution of the electrical impulses and axon potentials along the 
nerves and inhibiting the signal from transportation between neurons. The dys-
function in transmitting the signals affects the body’s different affecting organs, as 
they do not receive a signal telling them what to do, leading to abnormal functions. 
Furthermore, and as the disease progresses, different parts of the body lose their 
normal functionality, in addition to perivascular inflammation and BBB break-
down (Rivera Jr & Watson, 2014).  
The word Sclerosis means scars, and multiple is attributed to many scars 
formed since the inflammation results in a damage of the myelin sheath in several 
sites (Stauffer, 2006). There are two forms of the disease, the relapsing-remitting 
(RRMS) which comprises relapse and remission episodes and is the dominant 
form in most MS cases (Riccio & Rossano, 2015). The other form is the primary 
progressive (PPMS) which features progressive neurological damages and a decay 
upon the beginning of the disease. 
Approximately 2.5 million people worldwide suffer from the disease with a ra-
tio of 2-3:1 of women being more affected than men (da Cunha Matta & Orsini, 
2017).    
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4.1 The diet as a complementary medicine  
Diet and lifestyle play a fundamental role in the human health and have a substan-
tial impact on the metabolism of human cells and the intestinal microbiome (Ric-
cio & Rossano, 2015). The diet participates in the regulation of proinflammatory 
molecules and keeps the intestinal microbiota at balance (da Cunha Matta & Orsi-
ni, 2017). Immunodeficiency and the likelihood of developing an infection are 
both associated with malnutrition (Calder et al., 2002). The western-style diets 
with high sugar, salt, red meat, SFA and low fiber intake have been shown to con-
tribute to an increased inflammatory response in humans (da Cunha Matta & Orsi-
ni, 2017). Diseases characterized by the inadequate production of proinflammatory 
eicosanoids derived from AA are shown to have a link with SFA intake (Krem-
myda et al., 2011).  
The dietary composition is suggested to have an effect on human cells by inter-
acting with enzymes, transcription factors and nuclear receptors (Riccio & Ros-
sano, 2015). This can evoke inflammatory and autoimmune responses by affecting 
the metabolism of certain amendments of cellular metabolism toward anabolism or 
catabolism. The microbiota of the gut is influenced by different kinds and amounts 
of dietary factors, which in turn influences the diversity of the constituents of the 
microbiota (Calder et al., 2002). Figure 1. Any alterations in the balance of micro-
biota can result in a change in the mucosal immune system. Because of that, any 
increase in the number of pathogenic microorganisms in the gut can lead to a 
weakened immune system, resulting in a higher inflammation, immune-metabolic- 
and degenerative diseases (Riccio & Rossano, 2015). Furthermore, the microbiota 
has an important functionality in producing neuro-active molecules that can influ-
4 Linking disease with lifestyle and dietary 
habits 
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ence both the CNS and the peripheral nervous system (Altowaijri et al., 2017); 
hence, a balanced microbiota is very important.  
 
4.2 How saturated fatty acids and trans-unsaturated fatty 
acids influence human cell metabolism and modulate 
inflammation  
The high consumption of SFA can be a leading cause of human chronic diseases 
because SFA alters the balance of the gut microbiota (Riccio & Rossano, 2015). 
Which affects the balance between the beneficial and harmful bacteria and results 
in a dysfunction in the intestinal immunity and a low-grade systemic inflamma-
tion. The consumption of SFA particularly of long chains can also have a major 
impact on increasing the levels of cholesterol, which can lead to an increased in-
flammation (Tvrzicka et al., 2011).  
trans-unsaturated FA also have a considerable effect on increasing the gut in-
flammation, which in turn contributes to increasing inflammation (Altowaijri et 
al., 2017). Additionally, they affect the metabolism of cis-unsaturated FA and 
prevent the body from utilizing them. Trans-unsaturated FA cause capillary ob-
struction and decreased vascular wall elasticity and cell membrane fluidity. In 
several studies, the intake of SFA was associated with an increased metabolic syn-
drome (Kremmyda et al., 2011). The intake of n-6 PUFA have been shown to 
result in an increased insulin sensitivity and alteration in the fat allocation along 
the body (Tvrzicka et al., 2011). The metabolic effects of n-6 PUFA include in-
creased mRNA for LDL receptors leading to increased cholesterol synthesis and 
enhanced activity of LDL receptors. The relationship between inflammation and 
dietary intake of PUFA is attributed to the fact that n-6 PUFA is the precursor to 
the proinflammatory eicosanoids production (Calder, 2006). Such molecules are 
generated by arachidonic acid, which is an n-6 PUFA.  
 
 
 
4.3 The molecular mechanisms of fatty acids in 
inflammation and Multiple sclerosis  
In order to understand the link between dietary interventions and MS, it is im-
portant to understand the molecular mechanisms of how dietary molecules, in this 
case, n-3 PUFA interact with enzymes and transcription factors in human cells 
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(Riccio & Rossano, 2015). There are factors that trigger an inflammation and play 
a role in the neuronal and axonal damage in the brain and spinal cord (Altowaijri 
et al., 2017). Such factors include the autoreactive T cells and B cells, mitochon-
drial dysfunction, and oxidative stress, in addition to lipid dysmetabolism. Both n-
3 PUFA and n-6 PUFA affect the nuclear receptors (NR) NFκB, PPAR, and 
SREBP-1c (Schmitz & Ecker, 2008). Such receptors are involved in a series of 
inflammatory signalling and in lipid metabolism. n-3 PUFA play a role in regulat-
ing the genes encoding inflammatory response and in lipid synthesis and impact 
the FA degradation. NR are ligand-activated transcription factors that control 
genes encoding lipid metabolism and inflammatory signalling (Schmitz & Ecker, 
2008). NFκB is a transcription factor belonging to the NR family and is essential 
for the production of inflammatory cytokines such as TNF-α.  
Oxidative metabolism is regulated by the enzymes AMP-activated kinase, 
Sirtuins (SIRT) and histone deacylating enzymes, in addition to a nuclear receptor 
featured by the isotypes of the peroxisome proliferator-activated receptors PPARs 
(Riccio & Rossano, 2015). The beta-oxidation of FA in mitochondria and peroxi-
somes are influenced by the PPARs isotypes. Which in turn regulate the gene tran-
scription that is engaged in the oxidation process, and form a network with AMPK 
and Sirtuins pathways. Such pathways are activated by low-calorie diets and phys-
ical exercise, besides the n-3 PUFA anti-inflammatory bioactive molecules.  
To understand the link between inflammation and the dietary intake of FA, it is 
essential to know which factors are involved in inflammation and autoimmunity 
(Riccio & Rossano, 2015). Such factors include the activation of the nuclear tran-
scription factor NFκB and the activator protein AP-1. Both of the aforementioned 
are activated in the case of MS and evoke the expression of proinflammatory 
genes and the production of proinflammatory molecules. It is unknown what is the 
underlying cause of their activation in the case of MS, NFκB can be activated due 
to several factors, such as viruses, oxidative stress and the intake of SFA. Contra-
riwise, EPA and DHA are activators of PPARα, which in turn inhibits NFκB and 
hence reduce inflammation (Schmitz & Ecker, 2008). EPA inhibits the activity of 
NFκB more efficiently in comparison to DHA.  
PPAR isotopes can make complexes with the retinoid X-receptor (RXR), the 
latter is activated by 9--cis-retinoic acid (RA) (Riccio & Rossano, 2015). The ster-
ol regulatory element-binding proteins (SREBP-1c and SREBP-2) are activated by 
diets such as the western-style diets, including high SFA intake. Furthermore, such 
diets also activate the carbohydrate responsive element-binding protein ChREBP.  
Both SREBP-1c and SREBP-2 are controlled by the “liver X” nuclear receptors 
(LXR), the latter is activated by cholesterol derivative oxysterols and glucose. 
LXR has a role in lipid-synthesis by activating SREBP-1c and inhibiting SREBP-
2.  
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Oxidative stress is increased by the intake of n-3 PUFA compared to the intake 
of n-6 PUFA (Kremmyda et al., 2011). The transcription of antioxidant enzymes 
(uncoupling protein 2, glutathione transferase 2τ, superoxide dismutase) is also 
increased by the dietary intake of n-3 PUFA. The repressed transcription of en-
zymes that establish the production of oxygen and nitrogen species (RONS) is also 
suppressed by the intake of n-3 PUFA.   
The course of relapse in MS that is characterized by new attacks of the autore-
active T cell to the myelin is a biosynthetic process, so dietary components that 
favour anabolism would promote the inflammatory status of MS and dietary com-
ponents that favour catabolism, will have the opposing effect (Riccio & Rossano, 
2015).  
 
4.4 Omega-3 anti-inflammatory molecules in treating 
Multiple sclerosis  
There are various disease-modifying drugs and therapies used to slow down or to 
prevent the progression of MS (Riccio & Rossano, 2015). Such therapies rely on 
targeting the inflammatory status of MS (Altowaijri et al., 2017), besides being 
merely effective in diminishing short-term morbidity (Riccio & Rossano, 2015). 
They can alleviate the progression and certain MS outcomes in some patients be-
cause each patient responds differently to such drugs. Such drugs and treatments 
do not cure the outcomes of MS, are of high costs and have serious side effects 
(Altowaijri et al., 2017). Therefore, it can be discussed whether an alternative 
therapy from a natural source could be more efficient in MS treatment than the 
used drugs (da Cunha Matta & Orsini, 2017). Several studies showed that the 
prevalence of MS in populations with higher intake of fish is less than in those 
with lower intake of fish, thus linking n-3 PUFA intake with an enhanced immuni-
ty and prevention of the onset of disease (Altowaijri et al., 2017). Besides the anti-
arrhythmic and antithrombotic effects, LC n-3 PUFA possess anti-inflammatory 
effects (Kremmyda et al., 2011). Such effects are typically characterized by a de-
creased production of the proinflammatory eicosanoids lipid-mediators derived 
from AA and inflammatory cytokines.  
Postprandial inflammation and the expression of proinflammatory molecules 
are reduced by the intake of n-3 PUFA (Riccio & Rossano, 2015). n-3 PUFA par-
ticularly derived from fish suppress the production of cholesterol and induce the 
oxidation of FA. The intake of EPA and DHA can reduce the production of in-
flammatory cytokines and antagonizes the excessive presence of eicosanoids (Cal-
der, 2006). There is a competition between n-3 PUFA and n-6 PUFA for the en-
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zymes to produce further eicosanoids. An excess of one of the PUFA families 
causes a decrease in the conversion of the other (Schmitz & Ecker, 2008). If the 
conversion is favoured for the n-3 family, there will be a significant decrease in 
the proinflammatory eicosanoids derived from n-6 family, resulting in a lowered 
inflammation. 
Both DHA and EPA possess anti-inflammatory properties and immune-
modulatory activities (Riccio & Rossano, 2015). DHA exists in the human brain 
and the concentrations of it are reduced in MS patients. It can, therefore, be dis-
cussed whether there is a link between n-3 PUFA and MS. Dietary components 
that contain arachidonic acid such as meat, or dietary components containing more 
n-6 than n-3 PUFA can be a contributing risk factor for MS patients. Therefore, 
the intake of them should be limited in MS patients to reduce the proinflammatory 
production of eicosanoids (Calder, 2006). The inflammatory processes in MS are 
suggested to be owing to the low ratio of n-3 PUFA in comparison to n-6 PUFA. 
This is logical since n-6 families are converted to proinflammatory eicosanoids 
that can affect the inflammatory status of MS.  
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Unfortunately, it is unclear whether there is a direct link between dietary habits 
and the case of MS since clinical trials involved in the research of this topic are 
not so many (Riccio & Rossano, 2015). There is no clear evidence that an imbal-
anced intestinal microbiota is a direct cause of MS. However, the anti-
inflammatory properties of n-3 PUFA are shown to help improve the overall quali-
ty of life (Altowaijri et al., 2017). Healthy dietary habits have a positive impact on 
MS outcomes such as reducing fatigue, relapse rate, physical disability, slowing 
down the progression of the disease and downregulating the production of proin-
flammatory molecules. 
A review by Calder that has been done at 2015 on the effects of marine n-3 FA 
on inflammatory processes concluded that the intake of n-3 PUFA reduces the 
amount of AA in the membrane of cells involved in inflammation (Calder, 2015). 
It was also concluded that some of the effects of n-3 PUFA particularly from fish 
on the inflammatory cells are mediated by alterations in the FA composition in the 
cell membrane.  
Experimental studies in a review by Simopoulos about the role of n-3 PUFA in 
inflammation and autoimmune diseases showed evidence that incorporating n-3 
PUFA amended inflammatory and immune reactions (Simopoulos, 2002). Conse-
quently, it can be argued that n-3 PUFA can be used as a therapeutic alternative in 
inflammatory and autoimmune disease such as MS. Further findings of the review 
were that there was a link between the pathophysiology of major depression and 
the alterations of FA composition and the production of proinflammatory eico-
sanoids and cytokines. This can also be implied to the MS-related depression.  
In MS, the expression of various proinflammatory genes besides the production 
of proinflammatory molecules is promoted (Riccio & Rossano, 2015). This can be 
triggered by some proinflammatory dietary components like SFA and trans-
unsaturated FA. In contrast to low-calorie diets, calorie-rich diets including the 
intake of SFA are considered to induce the production of proinflammatory mole-
cules. A review of the nutrition facts in MS by Riccio and Rossano reviewed stud-
5 Discussion  
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ies from the 1950s by Swank and Goodwin. The studies demonstrated that the 
development of MS is related to the intake of SFA of animal origin and that the 
consumption of such FA results in the synthesis of storage lipids and cholesterol 
leading to an increased inflammation (reviewed by Riccio & Rossano, 2015). SFA 
decreases membrane fluidity and obstructs CNS capillaries consequently causing 
inflammation and demyelination (Altowaijri et al., 2017). A diet based on the low 
consumption of SFA was designed by Swank to emphasize the link between the 
prevalence of MS and high intake of SFA, it was shown that following this diet 
could decrease the physical disability and progression of MS (Altowaijri et al., 
2017).  
In a review by Wall et al. 2010, it was concluded that the high intake of n-3 
PUFA alters the production of proinflammatory eicosanoids derived from AA and 
regulates the inflammation and immune responses (Wall et al. 2010). Consuming 
n-3 PUFA was linked with decreased prevalence of chronic diseases and an im-
proved mental health.  
In an Australian case-control study done for the Ausimmune Investigator 
Group, the role of total FA intake in the risk of first clinical diagnosis (FCD) of 
CNS demyelination was investigated (Hoare et al., 2016). In four regions of Aus-
tralia, 267 FCD cases and 517 matching controls included. The dietary data were 
obtained by utilizing a validated food frequency questionnaire within four years. 
Main findings were that the high intake of n-3 PUFA specifically from fish was 
connected to a reduced risk of FCD. The study also compared different other stud-
ies such as a Swedish population-based case study of newly diagnosed MS pa-
tients, which connected n-3 PUFA intake to a lowered risk of developing MS. Two 
other studies were also reviewed, performed in France and Poland, both suggested 
that there was no link between the total consumption of FA and MS. It is not clear 
what type of FA was reviewed in both of the studies, therefore they are not con-
sidered reliable. The studies were designed differently and the data collection 
methodology was obscure and unclear in the French and Polish ones (Hoare et al., 
2016). Additionally, poor information was provided about the overall dietary hab-
its in relation to the diagnosis of MS. The studies were performed on a different 
form and stage of the disease (Hoare et al., 2016), in addition to that each patient 
has his own individual case, which is not similar to others (Riccio & Rossano, 
2015). Nine regional Human Research Ethics Committees approved the study by 
Hoare. The conclusion of the Ausimmune study was that there was a significant 
decrease in the risk of FCD of the CNS demyelination associated with the high 
intake of n-3 PUFA particularly from fish (Hoare et al., 2016). 
It should be taken into account that there are other factors influencing the case 
of each individual patient, like the overall dietary habits and lifestyle (Altowaijri et 
al., 2017). The overall eating habits play a considerable role in reducing the out-
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comes of MS such as fatigue, depression, relapsing rate, and physical disability. 
This is attributed to that a healthy diet improves the overall quality of life and en-
hances the immune system. It is suggested that another contributing factor that 
might trigger the onset of the disease is smoking (Riccio & Rossano, 2015). It 
might not be a direct cause of MS but may definitely reduce the health-related 
quality of life of smoking individuals compared to non-smokers. Another assisting 
factor that might lead to MS is hyper-caloric diets since the consumption of re-
fined carbohydrates and sugar triggers the insulin levels to increase and result in 
the production of proinflammatory molecules and free radicals.  
An international survey assessed the connection between dietary factors and 
health-related quality of life (Altowaijri et al., 2017). It showed that the high in-
take of n-3 PUFA was associated with a better quality of life and less physical 
disability and fatigue in MS patients. Evidence from a number of studies shows 
that the intake of n-3 PUFA is associated with lower inflammatory cytokine pro-
duction (Kremmyda et al., 2011). The intake of EPA has been shown to reduce the 
degradation of the skeletal muscles and reduce the expression of proteasome activ-
ity.  
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In summary, incorporating dietary interventions as an alternative or complemen-
tary medicine in MS can be beneficial, by controlling and reducing the inflamma-
tory status of MS, through reducing the postprandial inflammation. In addition to 
retaining the intestinal microbiota in balance to suppress intestinal- and systemic-
inflammation and enhance immunity.  
The consumption of n-3 PUFA is shown to help to improve the physical and men-
tal health-related quality of life. n-3 derived eicosanoids possess anti-inflammatory 
properties that might help in the case of MS, by reducing the production of proin-
flammatory molecules. DHA and EPA possess anti-inflammatory properties and 
immune-modulatory activities.  
Studies showed that the high intake of n-3 PUFA specifically from fish was 
linked with a lowered progression, fatigue, depression and physical disability in 
MS patients.  
More information and data should be provided regarding the diet-gene interac-
tions. As well as the role of nutrigenomics and the environmental modifications to 
gain a boosted immune system functionality and prevention against disease.  
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7.1 Table1. n-3 content in different fish species, developed by using Table 1 from the 
review by (Wall et al., 2010).  
Fish species n-3 (EPA&DHA) content per 100 g fish 
Atlantic herring 2.01 
Atlantic salmon 1.28-2.15 
Sardines 1.15-2 
Rainbow trout 1.15 
Tuna 
Tuna (canned) 
0.28-1.51 
                                   0.31 
Cod 
Scallop 
0.28 
0.2 
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7.2 Figure 1.  
 
 
 
Figure 1. How the diet affects the human heath in two ways: (A) the metabolism of human cells and 
(B) the population of the human gut microbiota (reviewed by Riccio & Rossano, 2015 
28 
 
Altowaijri, G., Fryman, A. & Yadav, V. (2017). Dietary Interventions and Multi-
ple Sclerosis. Current Neurology and Neuroscience Reports 17(3). 
 
Brodal, P. (2010). PART I MAIN FEATURES OF STRUCTURE AND FUNC-
TION. In: Brodal, P. The central nervous system : structure and function. 4th ed. 
ed. New York: New York : Oxford University Press, pp 23- 62.  
 
Calder, P.C. (2006). n-3 polyunsaturated fatty acids, inflammation, and inflamma-
tory diseases. American Journal of Clinical Nutrition 83(6), 1505S-1519S. 
 
Calder, P.C. (2015). Marine omega-3 fatty acids and inflammatory processes: 
Effects, mechanisms and clinical relevance. Biochimica et Biophysica Acta - Mo-
lecular and Cell Biology of Lipids 1851(4), pp. 469-484. 
 
Ceribelli, A., Generali, E., Selmi, C. (2016). Environment and Autoimmunity: 
Facts and Gaps. In: Esser, C., Environmental Influences on the Immune System. 1st 
ed. 2016. ed. Vienna: Vienna : Springer Vienna : Imprint: Springer, pp. 305-320.  
 
da Cunha Matta, A.P. & Orsini, M. (2017). Multiple Sclerosis: Food and Lifestyle 
in a Neurological Autoimmune Disease. In: Nutrition and Lifestyle in Neurologi-
cal Autoimmune Diseases: Multiple Sclerosis, pp. 47-51.  
 
Devereux, G. (2002). 1. The Immune System: an Overview. In: Calder, P.C., 
Field, C.J., Gill, H.S. Nutrition and immune function. Wallingford: Wallingford : 
CABI Pub. in association with the Nutrition Society, pp. 1-20.  
 
Esser, C. (2016). Principles of the Immune System: Players and Organization. In: 
Esser, C., Environmental Influences on the Immune System. 1st ed. 2016. ed. Vi-
enna: Vienna : Springer Vienna : Imprint: Springer, pp. 1-17.  
References 
29 
 
 
Hoare, S., Lithander, F., Van Der Mei, I., Ponsonby, A.L., Lucas, R., Chapman, 
C., Coulthard, A., Dear, K., Dwyer, T., Kilpatrick, T., Lucas, R.M., McMichael, 
T., Pender, M.P., Taylor, B., Valery, P.C. & Williams, D. (2016). Higher intake of 
omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first 
clinical diagnosis of central nervous system demyelination: Results from the 
Ausimmune Study. Multiple Sclerosis 22(7), pp. 884-892. 
 
Kremmyda, L.S., Tvrzicka, E., Stankova, B. & Zak, A. (2011). Fatty acids as bio-
compounds: Their role in human metabolism, health and disease - a review. part 2: 
Fatty acid physiological roles and applications in human health and disease. Bio-
medical Papers 155(3), pp. 195-218. 
 
Mir, S.M., Kanjilal, S. & Ahmed, S.U. (2016). Omega-3 fatty acids in inflammato-
ry diseases. In: Omega-3 Fatty Acids: Keys to Nutritional Health. pp. 141-155. 
Riccio, P. & Rossano, R. (2015). Nutrition facts in multiple sclerosis. ASN Neuro 
7(1), pp. 1-20. 
 
Rivera Jr, G.L. & Watson, R.R. (2014). Chapter 30 - Multiple Sclerosis: Modifica-
tion by Fish Oil. In: Omega-3 Fatty Acids in Brain and Neurological Health. Bos-
ton: Academic Press. ISBN 978-0-12-410527-0, pp. 367-371.  
 
Schmitz, G. & Ecker, J. (2008). The opposing effects of n-3 and n-6 fatty acids. 
Progress in Lipid Research 47(2), pp.147-155. 
 
Simopoulos, A.P. (2002). Omega-3 Fatty Acids in Inflammation and Autoimmune 
Diseases. Journal of the American College of Nutrition 21(6), 495-505. 
 
Stauffer, M. (2006). 2. What is MS?. In: Understanding multiple sclerosis. 1st ed. 
ed. Jackson: Jackson : University Press of Mississippi, pp. 16-28.  
 
Tvrzicka, E., Kremmyda, L.S., Stankova, B. & Zak, A. (2011). Fatty acids as bio-
compounds: Their role in human metabolism, health and disease - a review. part 1: 
Classification, dietary sources and biological functions. Biomedical Papers 155(2), 
pp.117-130. 
 
Wall, R., Ross, R.P., Fitzgerald, G.F. & Stanton, C. (2010). Fatty acids from fish: 
the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutrition 
Reviews 68(5), pp. 280-289. 
